ロード中...
A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer
Comparative results of second- or later-line bevacizumab plus docetaxel and docetaxel alone for patients with NSCLC have never been reported. In order to evaluate the combined effect of bevacizumab and docetaxel as second- or later-line chemotherapy for NSCLC, a retrospective study was performed. Be...
保存先:
| 出版年: | Mol Clin Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492640/ https://ncbi.nlm.nih.gov/pubmed/28685090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1282 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|